BenBenBen etc25 Sep 2020 17:25
Thanks for the update Ben
Having done a fair amount of press work and being friendly with several high profile journalist (with whom I often discuss the news) I'd suggest a few of the above posts are likely happening in parallel:
- As Chengdo says, Avacta are unlikely to be pursing coverage to manage any reputational risk and over-expectation. They have a PR company to address this when the validation process has completed and in any case, the test will promote itself
- Certainly no D-notice but I think an NDA is highly likely; it's clearly stated as part of the CONDOR process and is standard for complex commercial negotiations: when the topic is also so politically sensitive and the government (read: Cummings) are well-known for ruthlessly controlling the narrative, it would be strange to think they would just leave this rather large story lying around
- Additionally, it's also a bit of a non-story, until now that is. To-date, a company may or may not make lots of a test currently being reviewed and the government may or may not buy lots of that test. There's no concrete information and column inches are precious, so why would an editor fill them with speculation. Sure, its a big story for *us*, but why would some guy, in say, Bolton, give two figs about it? This was always the test a friend of mine would put to me when I tried to get coverage on things
- That said, as of today testing is on the front page of every newspaper; so I would expect coverage to start to emerge. Westminster may stay tight-lipped but I wouldn't be surprised if a few pieces start to emerge in the coming days as reporters start to join the dots now the interest is piquing. In any case, I messaged a few friends, including the person covering testing at the FT - so heres hoping!
Sign In
Follow the stocks
